These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9745824)

  • 1. [Impact of anti-retroviral treatment with protease inhibitors on the evolution of cytomegalovirus retinitis in the patient carrying acquired immunodeficiency syndrome].
    Postelmans L; Gerard M; Sommereijns B; Caspers L; Clumeck N; Libert J
    Bull Soc Belge Ophtalmol; 1997; 267():133-44. PubMed ID: 9745824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
    Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Rudent A; Lantz O; Lecointe D; Furlan V; Delfraissy JF; Offret H
    J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytomegalovirus retinitis in patients with human immunodeficiency virus infection].
    Mesarić B; Begovac J; Ugrinović N; Babić K; Lisić M
    Lijec Vjesn; 1998 May; 120(5):106-10. PubMed ID: 9748786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing survival in AIDS patients with cytomegalovirus retinitis treated with combination antiretroviral therapy including HIV protease inhibitors.
    Walsh JC; Jones CD; Barnes EA; Gazzard BG; Mitchell SM
    AIDS; 1998 Apr; 12(6):613-8. PubMed ID: 9583601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Course of cytomegalovirus retinitis in HIV positive patients treated with triple antiretroviral therapy].
    Doan S; Badelon I; Chaine G
    J Fr Ophtalmol; 1998 Jan; 21(1):34-41. PubMed ID: 9834898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.
    van den Horn GJ; Meenken C; Danner SA; Reiss P; de Smet MD
    Br J Ophthalmol; 1998 Sep; 82(9):988-90. PubMed ID: 9893585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
    Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG
    Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis.
    Sungkanuparph S; Overton ET; Seyfried W; Groger RK; Fraser VJ; Powderly WG
    Clin Infect Dis; 2005 Nov; 41(9):1326-32. PubMed ID: 16206110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progress in the studies on cytomegalovirus retinitis].
    Li HY; Ye JJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):223-7. PubMed ID: 12905727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology and incidence of cytomegalovirus retinitis in the HIV population in Singapore over 6 years.
    Teoh SC; Wang PX; Wong EP
    Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7546-52. PubMed ID: 23074211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
    Badelon I; Gohier P; Chaine G
    J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical course of cytomegalovirus retinitis with the different antiretroviral therapies in our hospital].
    Moreno Ruiz O; Ferrer Novella E; Torrón Fernández C; Arazo Garcés P; Melcon Sánchez B; Honrubia López FM
    Arch Soc Esp Oftalmol; 2001 Jul; 76(7):397-402. PubMed ID: 11438875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease inhibitors linked to drop in CMV retinitis.
    AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for cytomegalovirus retinitis in HIV-positive and AIDS patients.
    Sandy CJ; Ferris JD; Bloom PA; Coker RJ; Pinching AJ; Migdal CS
    QJM; 1995 Dec; 88(12):899-903. PubMed ID: 8593550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mycobacterium avium complex disease in HIV seropositive patients: incidence and risk factors before and after the introduction of highly active antiretroviral treatments. Clinical Epidemiology Group of the Information and Care Center for Human Immunodeficiency].
    Mary-Krause M; Rabaud C; Jouan M; Obadia M; de la Blanchardière A; Raffi F; May T
    Pathol Biol (Paris); 2000 Jun; 48(5):495-504. PubMed ID: 10949848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.